サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1386409

エクソソーム治療市場レポート：2030年までの動向、予測、競合分析

Exosome Therapeutics Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

エクソソーム治療市場レポート：2030年までの動向、予測、競合分析
出版日: 2023年10月03日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

エクソソーム治療の動向と予測

世界のエクソソーム治療市場は、2024年から2030年までのCAGRが25.7%で、2030年までに推定18億米ドルに達すると予想されます。この市場の主な促進要因は、エクソソーム治療の可能性に対する意識の高まり、エクソソーム治療の開発・商業化に対する政府支援の拡大、世界の慢性疾患の有病率の上昇です。世界のエクソソーム治療市場の将来は、研究・学術機関および病院・診断センター市場における機会によって有望視されています。

エクソソーム治療市場の洞察

Lucintel社は、天然エキソソームはハイブリッドエキソソームよりも豊富で、製造が容易で、生体適合性が高く、保存期間が長いため、予測期間中も最大セグメントであり続けると予測しています。

この市場の中では、エクソソーム治療研究の需要が高いことから、研究機関や学術機関が引き続き大きなセグメントを占めると予想されます。

北米は、研究開発インフラが充実しており、規制環境も良好であることから、引き続き最大の市場です。

本レポートでは、以下の11の主要な質問に回答している：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界のエクソソーム治療市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界のエクソソーム治療市場動向（2018～2023年）と予測（2024～2030年）
  • タイプ別の世界のエクソソーム治療市場
    • 天然エクソソーム
    • ハイブリッドエクソソーム
  • 用途別の世界のエクソソーム治療市場
    • 代謝障害
    • オンコロジー
    • 心臓疾患
    • 神経内科
    • 炎症性疾患
    • 臓器移植
    • 婦人科疾患
    • 血液疾患
    • その他
  • 最終用途別の世界のエクソソーム治療市場
    • 研究および学術機関
    • 病院と診断センター

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界のエクソソーム治療市場
  • 北米のエクソソーム治療市場
  • 欧州のエクソソーム治療市場
  • アジア太平洋地域のエクソソーム治療市場
  • その他地域エクソソーム治療市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • タイプ別の世界のエクソソーム治療市場の成長機会
    • 用途別の世界のエクソソーム治療市場の成長機会
    • 最終用途別の世界のエクソソーム治療市場の成長機会
    • 地域別の世界のエクソソーム治療市場の成長機会
  • 世界のエクソソーム治療市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界のエクソソーム治療市場の能力拡大
    • 世界のエクソソーム治療市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Church & Dwight
  • GSK
  • Pfizer
  • Sun Pharmaceutical
  • Takeda Pharmaceutical
  • F. Hoffmann-La Roche
  • CELGENE Corporation
目次

Exosome Therapeutics Trends and Forecast

The future of the global exosome therapeutics market looks promising with opportunities in the research & academic institute and hospital & diagnostic center markets. The global exosome therapeutics market is expected to reach an estimated $1.8 billion by 2030 with a CAGR of 25.7% from 2024 to 2030. The major drivers for this market are increasing awareness towards the potential of exosome therapeutics, growing government supports for development and commercialization of exosome therapeutics, and rising prevalence of chronic diseases across the globe.

A more than 150-page report is developed to help in your business decisions.

Exosome Therapeutics by Segment

The study includes a forecast for the global exosome therapeutics by type, application, end use, and region.

Exosome Therapeutics Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Natural Exosome
  • Hybrid Exosome

Exosome Therapeutics Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Metabolic Disorders
  • Oncology
  • Cardiac Disorders
  • Neurology
  • Inflammatory Disorders
  • Organ Transplantation
  • Gynecology Disorders
  • Blood Disorders
  • Others

Exosome Therapeutics Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Research & Academic Institutes
  • Hospitals & Diagnostic Centers

Exosome Therapeutics Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Exosome Therapeutics Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies exosome therapeutics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the exosome therapeutics companies profiled in this report include-

  • Church & Dwight
  • GSK
  • Pfizer
  • Sun Pharmaceutical
  • Takeda Pharmaceutical
  • F. Hoffmann-La Roche
  • Celgene Corporation

Exosome Therapeutics Market Insights

Lucintel forecasts that natural exosome will remain the largest segment over the forecast period due to as more abundant, easier to produce, more biocompatible, and have a longer shelf life than hybrid exosomes.

Within this market, research and academic institutes is expected to remain the larger segment due to high demand for exosome therapeutics research.

North America will remain the largest region due to well-funded research and development infrastructure and the favorable regulatory environment in the region.

Features of the Global Exosome Therapeutics Market

Market Size Estimates: Exosome therapeutics market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Exosome therapeutics market size by type, application, end use, and region in terms of value ($B).

Regional Analysis: Exosome therapeutics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, end uses, and regions for the exosome therapeutics market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the exosome therapeutics market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the exosome therapeutics market size?

Answer: The global exosome therapeutics market is expected to reach an estimated $1.8 billion by 2030.

Q.2 What is the growth forecast for exosome therapeutics market?

Answer: The global exosome therapeutics market is expected to grow with a CAGR of 25.7% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the exosome therapeutics market?

Answer: The major drivers for this market are increasing awareness towards the potential of exosome therapeutics, growing government supports for development and commercialization of exosome therapeutics, and rising prevalence of chronic diseases across the globe.

Q4. What are the major segments for exosome therapeutics market?

Answer: The future of the exosome therapeutics market looks promising with opportunities in the research & academic institute and hospital & diagnostic center markets.

Q5. Who are the key exosome therapeutics market companies?

Answer: Some of the key exosome therapeutics companies are as follows:

  • Church & Dwight
  • GSK
  • Pfizer
  • Sun Pharmaceutical
  • Takeda Pharmaceutical
  • F. Hoffmann-La Roche
  • Celgene Corporation

Q6. Which exosome therapeutics market segment will be the largest in future?

Answer: Lucintel forecasts that natural exosome will remain the larger segment over the forecast period as it is abundant in nature, more biocompatible, and possess a longer shelf life than hybrid exosomes.

Q7. In exosome therapeutics market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to well-funded research and development infrastructure and the favorable regulatory environment in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the exosome therapeutics market by type (natural exosome and hybrid exosome), application (metabolic disorders, oncology, cardiac disorders, neurology, inflammatory disorders, organ transplantation, gynecology disorders, blood disorders, and others), end use (research & academic institutes and hospitals & diagnostic centers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Exosome Therapeutics Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Exosome Therapeutics Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Exosome Therapeutics Market by Type
    • 3.3.1: Natural Exosome
    • 3.3.2: Hybrid Exosome
  • 3.4: Global Exosome Therapeutics Market by Application
    • 3.4.1: Metabolic Disorders
    • 3.4.2: Oncology
    • 3.4.3: Cardiac Disorders
    • 3.4.4: Neurology
    • 3.4.5: Inflammatory Disorders
    • 3.4.6: Organ Transplantation
    • 3.4.7: Gynecology Disorders
    • 3.4.8: Blood Disorders
    • 3.4.9: Others
  • 3.5: Global Exosome Therapeutics Market by End Use
    • 3.5.1: Research & Academic Institutes
    • 3.5.2: Hospitals & Diagnostic Centers

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Exosome Therapeutics Market by Region
  • 4.2: North American Exosome Therapeutics Market
    • 4.2.2: North American Exosome Therapeutics Market by End Use: Research & Academic Institutes and Hospitals & Diagnostic Centers
  • 4.3: European Exosome Therapeutics Market
    • 4.3.1: European Exosome Therapeutics Market by Type: Natural Exosome and Hybrid Exosome
    • 4.3.2: European Exosome Therapeutics Market by End Use: Research & Academic Institutes and Hospitals & Diagnostic Centers
  • 4.4: APAC Exosome Therapeutics Market
    • 4.4.1: APAC Exosome Therapeutics Market by Type: Natural Exosome and Hybrid Exosome
    • 4.4.2: APAC Exosome Therapeutics Market by End Use: Research & Academic Institutes and Hospitals & Diagnostic Centers
  • 4.5: ROW Exosome Therapeutics Market
    • 4.5.1: ROW Exosome Therapeutics Market by Type: Natural Exosome and Hybrid Exosome
    • 4.5.2: ROW Exosome Therapeutics Market by End Use: Research & Academic Institutes and Hospitals & Diagnostic Centers

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Exosome Therapeutics Market by Type
    • 6.1.2: Growth Opportunities for the Global Exosome Therapeutics Market by Application
    • 6.1.3: Growth Opportunities for the Global Exosome Therapeutics Market by End Use
    • 6.1.4: Growth Opportunities for the Global Exosome Therapeutics Market by Region
  • 6.2: Emerging Trends in the Global Exosome Therapeutics Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Exosome Therapeutics Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Exosome Therapeutics Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Church & Dwight
  • 7.2: GSK
  • 7.3: Pfizer
  • 7.4: Sun Pharmaceutical
  • 7.5: Takeda Pharmaceutical
  • 7.6: F. Hoffmann-La Roche
  • 7.7: CELGENE Corporation